Literature DB >> 21449566

Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1).

Galyna P Volynets1, Maksym O Chekanov, Anatoliy R Synyugin, Andriy G Golub, Oleksandr P Kukharenko, Volodymyr G Bdzhola, Sergiy M Yarmoluk.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) has recently emerged as an attractive therapeutic target for the treatment of cardiac and neurodegenerative disorders. The selective inhibitors of ASK1 may become important compounds for the development of clinical agents. We have identified the ASK1 inhibitor among 3H-naphtho[1,2,3-de]quinoline-2,7-diones using receptor-based virtual screening. In vitro kinase assay revealed that ethyl 2,7-dioxo-2,7-dihydro-3H-naphtho[1,2,3-de]quinoline-1-carboxylate (NQDI-1) inhibited ASK1 with a K(i) of 500 nM. The competitive character of inhibition is demonstrated in Lineweaver-Burk plots. In our preliminary selectivity study this compound exhibited strong specific inhibitory activity toward ASK1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449566     DOI: 10.1021/jm200117h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.

Authors:  X Wang; M Nachliely; J S Harrison; M Danilenko; G P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2018-11-30       Impact factor: 4.292

2.  Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.

Authors:  Andrii Monastyrskyi; Simon Bayle; Victor Quereda; Wayne Grant; Michael Cameron; Derek Duckett; William Roush
Journal:  Bioorg Med Chem Lett       Date:  2017-12-13       Impact factor: 2.823

3.  ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Authors:  John T Liles; Britton K Corkey; Gregory T Notte; Grant R Budas; Eric B Lansdon; Ford Hinojosa-Kirschenbaum; Shawn S Badal; Michael Lee; Brian E Schultz; Sarah Wise; Swetha Pendem; Michael Graupe; Laurie Castonguay; Keith A Koch; Melanie H Wong; Giuseppe A Papalia; Dorothy M French; Theodore Sullivan; Erik G Huntzicker; Frank Y Ma; David J Nikolic-Paterson; Tareq Altuhaifi; Haichun Yang; Agnes B Fogo; David G Breckenridge
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

Review 4.  Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

Authors:  Daniel J de Klerk; Mark J de Keijzer; Lionel M Dias; Jordi Heemskerk; Lianne R de Haan; Tony G Kleijn; Leonardo P Franchi; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

5.  Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.

Authors:  Onkar Singh; Anthony Shillings; Peter Craggs; Ian Wall; Paul Rowland; Tadeusz Skarzynski; Clare I Hobbs; Phil Hardwick; Rob Tanner; Michelle Blunt; David R Witty; Kathrine J Smith
Journal:  Protein Sci       Date:  2013-07-03       Impact factor: 6.725

6.  Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm.

Authors:  Yuyu Song; Maria Nagy; Weiming Ni; Navneet K Tyagi; Wayne A Fenton; Francesc López-Giráldez; John D Overton; Arthur L Horwich; Scott T Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

7.  Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.

Authors:  Emmanuel Sturchler; Weimin Chen; Timothy Spicer; Peter Hodder; Patricia McDonald; Derek Duckett
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

Review 8.  Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors.

Authors:  Francis Giraud; Elisabeth Pereira; Fabrice Anizon; Pascale Moreau
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

Review 9.  Therapeutic targets in the ASK1-dependent stress signaling pathways.

Authors:  Ryoichi Hayakawa; Teruyuki Hayakawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

10.  BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.

Authors:  Yukie Tanaka; Takayuki Komatsu; Hiroko Shigemi; Takahiro Yamauchi; Yutaka Fujii
Journal:  BMC Cancer       Date:  2014-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.